Letters to the editor [2]

Value in Health

Volumn 4, Issue 3, 2001, Pages 278-

  Berger, M ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COST EFFECTIVENESS ANALYSIS; HEALTH CARE MANAGEMENT; LETTER; PHARMACOECONOMICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; RESOURCE ALLOCATION; SOCIAL WELFARE; COST BENEFIT ANALYSIS; ECONOMICS; HEALTH SERVICES RESEARCH; METHODOLOGY; NOTE;

COST-BENEFIT ANALYSIS; ECONOMICS, PHARMACEUTICAL; GUIDELINES; HEALTH SERVICES RESEARCH;

EID: 18044401075     PISSN: 10983015     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1524-4733.2001.43102.x     Document Type: Letter

References (3)

1. The once and future application of cost-effectiveness analysis
2. Indirect costs of ischemic heart disease to employers
3. The employer's perspective